background
recent
viral
infect
patient
hematolog
malign
concern
primarili
allogen
hematopoiet
stem
cell
transplant
hsct
recipi
last
year
chang
treatment
regimen
nontranspl
patient
hematolog
malign
potenti
increas
incid
viral
infect
group
studi
prospect
investig
preval
broad
rang
respiratori
virus
nasopharyng
aspir
npa
well
virus
commonli
reactiv
allogen
hsct
methodologyprincip
find
patient
hematolog
malign
therapi
induc
neutropenia
n
screen
regard
broad
rang
common
respiratori
virus
nasopharynx
virus
commonli
detect
sever
immunosuppress
patient
peripher
blood
quantit
pcr
use
detect
virus
viral
pathogen
detect
patient
detect
rate
rather
similar
blood
npa
polyoma
bk
viru
rhinoviru
domin
pathogen
blood
npa
respect
patient
chronic
lymphocyt
leukemia
cll
patient
fever
overrepres
virusposit
group
furthermor
viral
find
npa
associ
upper
respiratori
symptom
urt
conclusionssignific
respiratori
viral
infect
low
titer
virus
blood
patient
neutropenia
common
patient
cll
patient
fever
independ
associ
infect
viral
find
npa
associ
urt
indic
activ
infect
find
motiv
studi
virus
impact
patient
categori
potenti
role
caus
agent
fever
neutropenia
reactiv
virus
blood
well
viral
respiratori
tract
infect
signific
impact
morbid
mortal
allogen
hematopoiet
stem
cell
transplant
hsct
recipi
although
rather
high
preval
respiratori
virus
neutropen
patient
fever
report
impact
viral
infect
nontranspl
set
neutropen
hematolog
patient
less
studi
addit
reactiv
cytomegaloviru
cmv
report
hematolog
neutropen
patient
undergon
allogen
hsct
fever
often
sign
infect
immunocompromis
patient
sinc
establish
caus
fever
neutropen
patient
difficult
empir
administr
broad
spectrum
antibiot
common
usag
strategi
substanti
decreas
mortal
rate
patient
group
bacteri
infect
document
approxim
onethird
fewer
febril
episod
patient
hematolog
malign
remain
home
cours
chemotherapi
includ
neutropen
phase
thu
expos
common
pathogen
circul
societi
consequ
epidemiolog
infect
hospit
patient
mirror
outpati
set
neutropen
hematolog
patient
allogen
hsct
recipi
prospect
evalu
presenc
broad
rang
respiratori
virus
nasopharyng
aspir
npa
well
virus
commonli
reactiv
allogen
hsct
patient
give
inform
written
consent
elig
enrol
studi
approv
region
ethic
review
board
stockholm
wwwepns
period
jan
adult
patient
hematolog
disord
present
karolinska
univers
hospit
stockholm
neutropenia
ask
particip
studi
patient
undergon
allogen
hematopoiet
stem
cell
transplant
hsct
within
previou
two
year
patient
admit
intens
care
unit
exclud
studi
patient
neutropen
fever
sampl
routin
microbi
cultur
upon
admiss
onset
fever
hospit
addit
studi
sampl
detect
virus
blood
nasopharyng
aspir
npa
collect
within
hour
fever
onset
upon
routin
medic
appoint
unselect
afebril
neutropen
patient
prospect
sampl
studi
sampl
within
hour
sampl
npa
store
analysi
quantit
realtim
pcr
qpcr
serum
use
blood
assay
except
cytomegaloviru
cmv
adenoviru
adv
whole
blood
plasma
use
respect
blood
specimen
detect
epsteinbarr
viru
ebv
cmv
adv
extract
analyz
qpcr
describ
qpcr
total
viral
nucleic
acid
extract
qiaamp
minelut
viru
spin
kit
qiagen
us
accord
manufactur
protocol
ml
specimen
elut
ml
extract
analysi
bk
viru
bkv
describ
elsewher
multiplex
realtim
pcr
assay
simultan
detect
cytomegaloviru
epsteinbarr
viru
adenoviru
bk
polyomaviru
hrmalm
et
al
manuscript
qpcr
parvoviru
perform
abi
realtim
pcr
system
appli
biosystem
carri
total
reaction
mixtur
includ
ml
taqman
univers
pcr
master
mix
appli
biosystem
ml
templat
tabl
npa
analyz
abi
system
describ
howev
rna
virus
multiscrib
rnase
inhibitor
mix
appli
biosystem
use
newli
develop
primer
probe
describ
tabl
wherea
human
rhinoviru
hrv
human
enteroviru
hev
influenza
viru
ifa
influenza
b
viru
ifb
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
design
describ
elsewher
quantif
virus
blood
achiev
compar
plasmid
known
concentr
viru
detect
nasopharynx
howev
judg
qualit
npa
use
start
materi
cmv
ebv
adv
dynam
rang
copiesml
valu
detect
viral
copi
rang
given
bkv
lower
part
dynam
rang
copiesreact
valu
detect
viral
copi
copiesml
blood
consid
patient
peripher
blood
mononuclear
cell
isol
phenotyp
character
made
stain
two
set
antibodi
bd
multitest
bd
bioscienc
sweden
follow
cell
surfac
marker
set
set
accord
manufactur
instruct
trucount
tube
bd
bioscienc
use
absolut
cell
count
neutropenia
defin
absolut
neutrophil
count
fever
defin
singl
temperatur
read
persist
hour
upper
respiratori
tract
symptom
urt
defin
onset
rhinorrhea
sneez
nasal
congest
cough
hoars
diagnosi
coagulaseneg
staphylococci
bacteremia
least
two
posit
blood
cultur
requir
clinic
routin
collect
laboratori
data
extract
patient
medic
record
univari
analys
perform
use
fischer
exact
test
categor
data
noncategor
variabl
compar
mannwhitney
utest
forward
condit
binari
logist
regress
analysi
perform
presenc
viru
depend
variabl
paramet
describ
tabl
pvalu
covari
test
twosid
pvalu
consid
signific
softwar
product
use
prism
window
pasw
statist
total
neutropen
patient
includ
tabl
patient
fever
unselect
afebril
neutropen
patient
case
particip
multipl
neutropen
episod
first
consid
studi
febril
patient
declin
npa
anoth
one
declin
collect
extra
blood
sampl
afebril
patient
sampl
complet
thu
total
patient
includ
present
febril
neutropenia
studi
sampl
viru
analysi
collect
upon
admiss
patient
within
hour
patient
within
hour
patient
within
hour
patient
admiss
total
patient
least
one
viru
type
detect
tabl
detect
rate
rather
similar
blood
npa
blood
bkv
domin
follow
cmv
npa
hrv
domin
follow
adv
one
viru
type
simultan
detect
nine
virusposit
patient
except
one
sampl
upon
fever
viral
load
blood
sampl
copiesml
follow
except
one
cmv
find
copi
ml
four
bkv
find
copi
ml
one
find
copiesml
figur
among
fever
episod
fifteen
patient
respiratori
viru
detect
npa
urt
compar
patient
without
urt
tabl
predomin
report
urt
cough
follow
rhinorrhea
sneez
nasal
congest
mention
one
viral
pathogen
detect
patient
febril
neutropenia
patient
concurr
document
bacteri
infect
convers
bacteri
infect
document
case
febril
neutropenia
viru
cooccur
figur
statist
signific
differ
group
regard
creactiv
protein
crp
level
fever
onset
number
day
fever
howev
number
day
intraven
antibiot
higher
patient
document
bacteri
infect
median
day
rang
compar
viru
median
rang
pathogen
found
median
rang
respect
chronic
lymphocyt
leukemia
cll
overrepres
virusposit
group
vs
tabl
even
though
border
line
signific
virus
like
detect
among
nonhodgkin
lymphoma
nhl
patient
vs
p
contrast
recipi
autolog
hsct
viru
posit
vs
regard
latest
treatment
underli
diseas
steroid
treatment
monoclon
antibodi
therapi
associ
viru
find
eight
eleven
given
combin
drug
posit
absolut
count
cell
popul
examin
lower
virusinfect
group
tabl
howev
differ
reach
statist
signific
except
cell
count
patient
prophylact
treatment
aciclovir
underrepres
virusposit
group
vs
total
patient
febril
neutropenia
viru
detect
compar
patient
without
fever
true
virus
detect
blood
well
virus
detect
npa
tabl
reactiv
virus
blood
associ
immunosuppress
perform
univari
analys
characterist
tabl
regard
febril
nonfebril
patient
differ
regard
gender
age
underli
diseas
howev
febril
patient
afebril
patient
antineoplast
drug
includ
latest
treatment
also
differ
use
steroid
vs
cell
count
popul
except
monocyt
significantli
higher
afebril
patient
multivari
regress
analysi
presenc
viru
depend
variabl
paramet
tabl
p
valu
less
covari
cll
fever
remain
independ
associ
presenc
viru
respect
report
hemorrhag
cystiti
case
detect
bkv
furthermor
unabl
show
associ
elev
serum
level
creatinin
presenc
bkv
data
shown
use
highli
sensit
method
identifi
broad
rang
virus
estim
preval
respiratori
virus
viremia
hematolog
patient
neutropenia
allogen
hsct
recipi
viral
infect
commonli
detect
patient
cll
nhl
among
subpopul
immunolog
cell
type
investig
declin
cell
count
associ
infect
viral
infect
associ
fever
specif
respiratori
virus
npa
associ
urt
although
major
viral
tabl
presenc
virus
peripher
blood
nasopharynx
patient
neutropenia
infect
cooccur
bacteri
infect
viral
bacteri
coinfect
common
proport
differ
viru
speci
npa
differ
earlier
larg
studi
chemali
et
al
adult
hematolog
patient
hrv
commonest
find
studi
could
explain
use
pcr
instead
cultur
moreov
studi
chemali
et
al
retrospect
includ
patient
document
posit
viral
cultur
howev
find
npa
compar
recent
studi
children
febril
neutropenia
pcr
use
moreov
except
corona
viru
piv
proport
viral
speci
correspond
well
studi
commun
acquir
pneumonia
geograph
area
latter
confirm
earlier
find
tempor
occurr
viral
infect
immunocompromis
patient
tend
mirror
occurr
commun
approxim
half
viral
find
viremia
bkv
cmv
domin
pathogen
compar
screen
young
children
febril
neutropenia
show
lower
frequenc
discrep
probabl
explain
fact
preval
latent
viral
infect
increas
age
shown
allogen
transplant
patient
bk
viral
load
copiesml
significantli
higher
risk
hemorrhag
cystiti
patient
viral
load
less
copiesml
recent
pediatr
studi
posthsct
popul
degre
bk
viremia
seem
predict
renal
urolog
overal
outcom
howev
less
immunosuppress
cohort
mostli
low
titer
report
symptom
diseas
associ
bkv
although
found
independ
associ
viral
find
fever
one
interpret
result
caution
discrep
grade
immunosuppress
febril
afebril
patient
furthermor
multivari
analysi
low
number
patient
carri
risk
small
sampl
bia
even
though
level
viru
blood
lower
expect
symptomat
diseas
independ
associ
prompt
question
whether
viral
load
suffici
gener
fever
furthermor
viral
respiratori
tract
infect
caus
fever
differ
viru
type
known
various
pyrogen
studi
patient
fever
complet
sampl
detect
virus
thu
risk
underestim
associ
fever
viral
find
although
bacteri
cultur
limit
sensit
interest
note
viru
exist
often
sole
pathogen
identifi
cofactor
bacteria
fact
pcr
highli
sensit
method
alway
rais
question
find
relev
howev
determin
associ
respiratori
virus
urt
indic
symptomat
infect
recent
viral
infect
regard
concern
hematolog
malign
primarili
patient
undergon
allogen
hsct
howev
last
year
use
monoclon
antibodi
direct
b
andor
cell
treatment
hematolog
malign
nhl
cll
potenti
increas
incid
viral
infect
group
well
two
diagnos
well
receiv
monoclon
antibodi
therapi
associ
detect
viru
materi
multivari
analysi
cll
show
independ
associ
risk
small
sampl
bia
allogen
hsct
recipi
lymphocytopenia
known
risk
factor
develop
lower
respiratori
tract
infect
reconstitut
lymphocyt
popul
known
reduc
risk
viremia
cmv
adv
studi
measur
cell
count
lower
virusposit
patient
differ
cell
count
statist
signific
function
lymphocyt
alter
treatment
underli
diseas
would
therefor
interest
investig
associ
cell
count
also
cell
function
risk
viral
infect
patient
categori
conclus
respiratori
viru
infect
low
titer
virus
blood
patient
neutropenia
common
patient
cll
patient
fever
independ
associ
infect
viral
find
npa
associ
urt
indic
activ
infect
although
small
studi
heterogen
group
hematolog
patient
possibl
proport
episod
febril
neutropenia
could
origin
viru
infect
larger
prospect
longitudin
studi
conduct
investig
possibl
causal
neutropen
fever
viral
infect
